21 related articles for article (PubMed ID: 25595713)
1. Evaluation of an in vitro experimental platform of human polarized intestinal epithelial monolayers for the hazard assessment of insecticidal proteins.
Zimmermann CS; Snow RF; Wilson-Mifsud B; LeRoy K; Boeckman C; Huang E; Mathesius CA; Roper JM; Hurley BP
Food Chem Toxicol; 2023 Nov; 181():114106. PubMed ID: 37852351
[TBL] [Abstract][Full Text] [Related]
2. Colonization versus carriage of Clostridium difficile.
Donskey CJ; Kundrapu S; Deshpande A
Infect Dis Clin North Am; 2015 Mar; 29(1):13-28. PubMed ID: 25595843
[TBL] [Abstract][Full Text] [Related]
3. Complete genome sequence of the Clostridium difficile laboratory strain 630Δerm reveals differences from strain 630, including translocation of the mobile element CTn5.
van Eijk E; Anvar SY; Browne HP; Leung WY; Frank J; Schmitz AM; Roberts AP; Smits WK
BMC Genomics; 2015 Jan; 16(1):31. PubMed ID: 25636331
[TBL] [Abstract][Full Text] [Related]
4. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
[TBL] [Abstract][Full Text] [Related]
5. Reinforcement of the intestinal mucus layer protects against Clostridium difficile intestinal injury in vitro.
Diebel LN; Liberati DM
J Am Coll Surg; 2014 Sep; 219(3):460-8. PubMed ID: 25067805
[TBL] [Abstract][Full Text] [Related]
6. Effect of host defenses on Clostridium difficile toxin-induced intestinal barrier injury.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2013 Apr; 74(4):983-89; discussion 989-90. PubMed ID: 23511135
[TBL] [Abstract][Full Text] [Related]
7. Human Clostridium difficile infection: altered mucus production and composition.
Engevik MA; Yacyshyn MB; Engevik KA; Wang J; Darien B; Hassett DJ; Yacyshyn BR; Worrell RT
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G510-24. PubMed ID: 25552581
[TBL] [Abstract][Full Text] [Related]
8. Correlation of the detection of Clostridium difficile toxins in stools and presence of the clostridia in tissues of children.
Guarner J; Bhatnagar J; Shane AL; Jones T; DeLeon-Carnes MN; Schemankewitz E; Zaki SR
Hum Pathol; 2010 Nov; 41(11):1586-92. PubMed ID: 20656321
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile-associated diarrhoea.
Elliott B; Chang BJ; Golledge CL; Riley TV
Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection.
Kelly CP; LaMont JT
Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylcholine and the intestinal mucus layer: in vitro efficacy against Clostridium difficile-associated polymorphonuclear neutrophil activation.
Olson A; Diebel LN; Liberati DM
Am J Surg; 2015 Mar; 209(3):493-7. PubMed ID: 25595713
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]